October 25, 2021
Company Info
| Industry | Medical Specialties |
|---|---|
| Sector | Health Technology |
| Employees | 120 |
| CEO | Mr. David Leo Fischel |
| Address | 4320 Forest Park Avenue Suite 100, St. Louis, MO 63108 |
|---|---|
| Phone | 1.314.678.6100 |
| Website | www.stereotaxis.com |
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Competitors
| Company Name | 3 Month %Change |
1 Year %Change |
|---|---|---|
| Stereotaxis, Inc. | -38.88% | 69.01% |
| Ventyx Biosciences, Inc. | n/a | n/a |
| Rani Therapeutics Holdings, Inc. | n/a | n/a |
| Aclaris Therapeutics, Inc. | 4.74% | 280.94% |
| Avidity Biosciences, Inc. | -4.48% | -23.93% |
Statement Summary
as of 4:10 ET PM 10/22/2021| Total Assets (MRQ) | 57.3 M |
|---|---|
| Total Liabilities (MRQ) | 15.3 M |
| Shareholders’ Equity (MRQ) | 42.0 M |
| Total Revenue (Annual) | 9.1 M |
| Net Income (Annual) | -1.2 M |
Earnings And Estimates
as of 4:10 ET PM 10/22/2021
| Current Qtr EPS Estimate | -0.04 |
|---|---|
| Current FY EPS Estimate | -0.15 |
| Long Term EPS Growth Estimate | 40.00 |
| Next Expected Earnings Date | // |
STXS vs S&P 500
as of 10/22/2021| Relative To S&P 500 |
STXS | |
|---|---|---|
| 4 Weeks | n/a | n/a |
| 12 Weeks | n/a | n/a |
| YTD | n/a | n/a |
Earnings Surprises
as of 4:10 ET PM 10/22/2021| Fiscal Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/2021 | -0.03 | -0.02 | -33.33% |
| 03/2021 | -0.03 | -0.02 | -25.00% |
| 12/2020 | -0.03 | -0.02 | -25.00% |
| 09/2020 | -0.03 | -0.03 | -10.00% |
| 06/2020 | -0.05 | -0.03 | -40.00% |
| 03/2020 | -0.03 | -0.03 | 0.00% |
| 09/2013 | -0.40 | -0.26 | -35.57% |
| 06/2013 | -0.55 | -0.37 | -33.90% |
Financial Strength
as of 4:10 ET PM 10/22/2021| Pre-Tax Margin | -13.37 |
|---|---|
| Net Margin | 62.79 |
| Operating Margin | -37.46 |
| Return On Equity | -13.18 |
| Return On Assets | -9.61 |
| Inventory Turnover (TTM) | 2.47 |
| Sales Growth (MRQ) | -6.70 |
Ratios
as of 4:10 PM ET 10/22/2021| Price/Earnings (TTM) | n/a |
|---|---|
| Price/Book (MRQ) | 11.84 |
| Price/Cash Flow (TTM) | 202.09 |
| Book Value (MRQ) | 0.49 |
| Quick Ratio (MRQ) | 3.80 |
| Current Ratio (MRQ) | 4.11 |
| Total Debt/Equity (MRQ) | 0.03 |
Short Interest
as of 4:00 PM ET 10/25/2021| % Short - 1.61% | |
| % Remaining Float - 98.39% |
| Current | Last Month | |
|---|---|---|
| Short Interest Date | 09/30/2021 | 09/15/2021 |
| Short Interest Shares | 1,011,309 | 1,142,489 |
| Short Interest Ratio | 2.8 | 3.3 |
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00
0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00
0,0.00
Cash from
Activities
0,0.00
0,0.00
Cash from
Fin. Activities
0,0.00
0,0.00
TOTAL ASSETS |
TOTAL LIABILITIES |
TOTAL EQUITY |
|---|---|---|
Balance Sheet
| M Y | ||||
|---|---|---|---|---|
| ASSETS | ||||
| Cash And Equivalents | 0,0.00 | |||
| Receivables | 0,0.00 | |||
| Inventories | 0,0.00 | |||
| Other Current Assets | 0,0.00 | |||
| Total Current Assets | 0,0.00 | |||
| Property, Plant & Equipment, Gross | 0,0.00 | |||
| Accumulated Depreciation & Depletion | 0,0.00 | |||
| Property, Plant & Equipment, Net | 0,0.00 | |||
| Intangibles | 0,0.00 | |||
| Other Non-Current Assets | 0,0.00 | |||
| Total Non-Current Assets | 0,0.00 | |||
| TOTAL ASSETS | 0,0.00 | |||
| Liabilities & Shareholder Equity | ||||
| Accounts Payable | 0,0.00 | |||
| Short Term Debt | 0,0.00 | |||
| Total Current Liabilities | 0,0.00 | |||
| Long Term Debt | 0,0.00 | |||
| Deferred Income Taxes | 0,0.00 | |||
| Other Non-Current Liabilities | 0,0.00 | |||
| Minority Interest | 0,0.00 | |||
| Total Non-Current Liabilities | 0,0.00 | |||
| Preferred Stock Equity | 0,0.00 | |||
| Common Stock Equity | 0,0.00 | |||
| Common Par | 0,0.00 | |||
| Additional Paid In Capital | 0,0.00 | |||
| Cumulative Translation Adjustment | 0,0.00 | |||
| Retained Earnings | 0,0.00 | |||
| Treasury Stock | 0,0.00 | |||
| Other Equity Adjustments | 0,0.00 | |||
| Total Capitalization | 0,0.00 | |||
| TOTAL EQUITY | 0,0.00 | |||
| TOTAL LIABILITIES & STOCK EQUITY | 0,0.00 | |||
| Total Common Shares Outstanding | 0,0.00 | |||
| Preferred Shares | 0,0.00 | |||
| Treasury Shares | 0,0.00 | |||
| Basic Weighted Shares Outstanding | 0,0.00 | |||
| Diluted Weighted Shares Outstanding | 0,0.00 | |||
| Number Of Employees | 0,0.00 | |||
| Number Of Part-Time Employees | 0,0.00 | |||
TOTAL REVENUES |
EBT Excluding Unusual Items |
NET INCOME |
|---|---|---|
Income Statement
| M Y | |
|---|---|
| Sales | 0,0.00 |
| Cost Of Sales | 0,0.00 |
| Gross Operating Profit | 0,0.00 |
| Selling, General, And Administrative Expenses | 0,0.00 |
| Research & Development | 0,0.00 |
| Operating Income Before D & A (EBITDA) | 0,0.00 |
| Depreciation & Amortization | 0,0.00 |
| Interest Income | 0,0.00 |
| Other Income - Net | 0,0.00 |
| Special Income / Charges | 0,0.00 |
| Total Income Before Interest Expenses (EBIT) | 0,0.00 |
| Interest Expense | 0,0.00 |
| Pre-Tax Income | 0,0.00 |
| Income Taxes | 0,0.00 |
| Minority Interest | 0,0.00 |
| Net Income From Continuing Operations | 0,0.00 |
| Net Income From Discontinued Operations | 0,0.00 |
| Net Income From Total Operations | 0,0.00 |
| Extraordinary Income/Losses | 0,0.00 |
| Income From Cum. Effect Of Acct. Change | 0,0.00 |
| Income From Tax Loss Carryforward | 0,0.00 |
| Other Gains / Losses | 0,0.00 |
| Total Net Income | 0,0.00 |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Preferred Dividends | 0,0.00 |
| Net Income Available To Common | 0,0.00 |
| Basic EPS From Continuing Ops. | 0,0.00 |
| Basic EPS From Discontinued Ops. | 0,0.00 |
| Basic EPS From Total Operations | 0,0.00 |
| Basic EPS From Extraordinary Inc. | 0,0.00 |
| Basic EPS From Cum Effect Of Accounting Change | 0,0.00 |
| Basic EPS From Tax Loss Carryf'd. | 0,0.00 |
| Basic EPS From Other Gains (Losses) | 0,0.00 |
| Basic EPS, Total | 0,0.00 |
| Basic Normalized Net Income/Share | 0,0.00 |
| EPS From Continuing Ops. | 0,0.00 |
| EPS From Discontinued Ops | 0,0.00 |
| EPS From Total Ops. | 0,0.00 |
| EPS From Extraord. Inc. | 0,0.00 |
| EPS From Cum Effect of Accounting Change | 0,0.00 |
| EPS From Tax Loss Carfd. | 0,0.00 |
| EPS From Other Gains (L) | 0,0.00 |
| EPS, Total | 0,0.00 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
0,0.00 |
| Dividends Paid Per Share | 0,0.00 |
CASH FROM OPERATIONS |
CASH FROM INVESTING ACTIVITIES |
CASH FROM FINANCING ACTIVITIES |
|---|---|---|
Cash Flow Statement
| M Y | ||||
|---|---|---|---|---|
| Cash Flow From Operating Activities | ||||
| Net Income (Loss) | 0,0.00 | |||
| Operating Gains/Losses | 0,0.00 | |||
| Gross Operating Profit | 0,0.00 | |||
| (Increase) Decrease In Receivables | 0,0.00 | |||
| (Increase) Decrease In Inventories | 0,0.00 | |||
| (Increase) Decrease In Other Current Assets | 0,0.00 | |||
| (Decrease) Increase In Other Current Liabilities | 0,0.00 | |||
| (Increase) Decrease In Other Working Capital | 0,0.00 | |||
| Other Non-Cash Items | 0,0.00 | |||
| Net Cash From Continuing Operations | 0,0.00 | |||
| Net Cash From Discontinued Operations | 0,0.00 | |||
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 0,0.00 | |||
| Sale Of Property, Plant & Equipment | 0,0.00 | |||
| Cash Used For Investing Activities | ||||
| Sale Of Short-Term Investments | 0,0.00 | |||
| Purchases Of Property, Plant & Equipment | 0,0.00 | |||
| Acquisitions | 0,0.00 | |||
| Purchases Of Short-Term Investments | 0,0.00 | |||
| Other Cash From Investing Activities | 0,0.00 | |||
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 0,0.00 | |||
| Issuance Of Debt | 0,0.00 | |||
| Cash Used For Financing Activities | ||||
| Issuance Of Capital Stock | 0,0.00 | |||
| Repayment Of Long-Term Debt | 0,0.00 | |||
| Repurchase Of Capital Stock | 0,0.00 | |||
| Payment Of Cash Dividends | 0,0.00 | |||
| Other Financing Charges, Net | 0,0.00 | |||
| Net Cash From Financing Activities | 0,0.00 | |||
| Effect Of Exchange Rate Changes | 0,0.00 | |||
| Net Change In Cash & Cash Equivalents | 0,0.00 | |||
Earnings Estimates
as of 4:10 ET PM 10/22/2021| Current Qtr (09/2021) |
Next Qtr (12/2021) |
|
|---|---|---|
| Consensus Estimate | $-0.04 | $-0.04 |
| # of Estimates | 4 | 4 |
| High Estimate | $-0.03 | $-0.02 |
| Low Estimate | $-0.07 | $-0.07 |
| Year Ago EPS | $-0.03 | $-0.02 |
| Year Over Year Growth Estimate | 65.37% | 109.36% |
| Current Yr (12/2021) |
Next Yr (12/2022) |
|
|---|---|---|
| Consensus Estimate | $-0.15 | $-0.16 |
| # of Estimates | 4 | 4 |
| High Estimate | $-0.12 | $-0.07 |
| Low Estimate | $-0.19 | $-0.29 |
| Year Ago EPS | $-0.11 | $-0.15 |
| Year Over Year Growth Estimate | 31.82% | 8.62% |
| Current Qtr (09/2021) |
Next Qtr (12/2021) |
Current Year (12/2021) |
Next Year (12/2022) |
|
|---|---|---|---|---|
| Consensus Estimate | $-0.04 | $-0.04 | $-0.15 | $-0.16 |
| # of Estimates | 4 | 4 | 4 | 4 |
| High Estimate | $-0.03 | $-0.02 | $-0.12 | $-0.07 |
| Low Estimate | $-0.07 | $-0.07 | $-0.19 | $-0.29 |
| Year Ago EPS | $-0.03 | $-0.02 | $-0.11 | $-0.15 |
| Year Over Year Growth Estimate | 65.37% | 109.36% | 31.82% | 8.62% |
Insider Information Summary
as of 09/30/2021| % Insiders - 15.45% | |
| % Remaining Total Shares - 84.55% |
| Current | 1 Month | |
|---|---|---|
| Net Insider Transaction | 150.00 K | -1.85 M |
| Shares Bought | 150.00 K | 150.00 K |
| Shares Sold | 0.00 | 2.00 M |
Insider Activity
| Transaction Date | Insider/Title | Transaction Type | Market Value | Shares | Average Price | Current Holdings | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Learn to Trade Like a Pro
Master The Market with the Help of Our Financial Experts
LATEST NEWS
Latest News
Stereotaxis To Present At Upcoming Investor Conferences
Sep 9, 2021 9:00 AM EDT
Stereotaxis Strengthens Board Of Directors With Appointment Of Myriam J. Curet, M.D.
Jul 26, 2021 9:00 AM EDT
Stereotaxis To Establish Global Headquarters In Downtown St. Louis Globe Building
Mar 8, 2021 9:00 AM EST
Stereotaxis Announces Long-Term CEO Performance Stock Award
Feb 24, 2021 4:05 PM EST
Stereotaxis To Present At Upcoming Investor Conferences
Feb 11, 2021 9:00 AM EST
First Hospitals In The World Adopt Genesis Robotic Technology For Cardiac Heart Rhythm Disorders
Sep 14, 2020 9:00 AM EDT
Stereotaxis CEO Invited To Speak On Plenary Panel At RAPS Convergence 2020
Sep 8, 2020 9:05 AM EDT
Stereotaxis To Present At Three Investor Conferences In September
Aug 28, 2020 9:05 AM EDT
Benefits Of Stereotaxis Robotic Technology In COVID-19 Patient Highlighted In Publication
Jul 13, 2020 9:05 AM EDT
Stereotaxis To Be Added To The Russell 2000® And Russell 3000® Indexes
Jun 22, 2020 9:05 AM EDT
Stereotaxis To Present At Cowen 5th Annual FutureHealth Conference
Jun 18, 2020 9:05 AM EDT
Stereotaxis Robotic Technology Now Referenced In Over 400 Scientific Publications
Jun 2, 2020 9:00 AM EDT
Stereotaxis Announces $15 Million Common Stock Financing
May 26, 2020 9:00 AM EDT
Stereotaxis To Present At Three Investor Conferences In March
Feb 26, 2020 4:06 PM EST
Stereotaxis To Ring The Opening Bell® Of The New York Stock Exchange
Jan 16, 2020 9:00 AM EST
Stereotaxis (STXS) Stock Gains on Patent Win
Sep 1, 2015 12:33 PM EDT
Stereotaxis (STXS) Stock Soars Today After FDA Clears Vdrive for Market Entry
Jan 5, 2015 12:06 PM EST
Insider Trading Alert - CODE, COV And STXS Traded By Insiders
Dec 9, 2014 11:37 AM EST
5 Stocks Ready to Break Out
Jan 17, 2014 1:24 PM EST
4 Stocks Under $10 Moving Higher
Jan 15, 2014 7:00 AM EST
Why Stereotaxis Inc. (STXS) is Up Today
Jan 7, 2014 12:06 PM EST
5 Stocks Poised for Breakouts
Dec 20, 2013 2:07 PM EST
Recent Articles from TheStreet
Stocks Mixed, China Warns on Delta, PayPal & Pinterest, Tom Brady's 600 TDs - 5 Things You Must Know
Stocks mixed into start of busiest week of the earnings season; China cautions on Delta variant surge; PayPal says it's not interested in a Pinterest takeover; Tesla pulls its FSD beta software and Tom Brady adds yet another milestone to his list of NFL records.
Guilfoyle: AT&T Results Leave Traders With a Choice
An eventual cut in dividend would be painful but healthy for future of telecom
Facebook Tops Q3 Earnings Forecast, Falls Light on Revenues As Apple Privacy Changes Bite
Facebook missed Street revenue forecasts, and said sales growth would slow over the final months of the year, as Apple's privacy changes hit social media ad sales.
CLOSE
CLOSE
CLOSE
CLOSE